Page last updated: 2024-08-22

diallyl disulfide and Carcinoma, Epidermoid

diallyl disulfide has been researched along with Carcinoma, Epidermoid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, C; Li, Z; Liu, D; Liu, X; Ma, H; Wang, X; Xu, K; Yin, X; Zhang, J; Zhang, R; Zhang, S	1
Chen, SC; Chung, JG; Lai, WW; Lin, JP; Yu, CS; Yu, FS	1

Other Studies

2 other study(ies) available for diallyl disulfide and Carcinoma, Epidermoid

Article	Year
Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma. Oncology reports, 2014, Volume: 32, Issue:4 Topics: Allyl Compounds; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Line, Tumor; Cell Survival; Cyclin B1; Cyclin-Dependent Kinases; Disulfides; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; rho GTP-Binding Proteins; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53	2014
Diallyl disulfide inhibits N-acetyltransferase activity and gene expression in human esophagus epidermoid carcinoma CE 81T/VGH cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2005, Volume: 43, Issue:7 Topics: Acetylation; Acetyltransferases; Allyl Compounds; Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Disulfides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Esophageal Neoplasms; Female; Flow Cytometry; Humans; Mice; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm	2005

Article

Year

Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma.

Oncology reports, 2014, Volume: 32, Issue:4

Topics: Allyl Compounds; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Line, Tumor; Cell Survival; Cyclin B1; Cyclin-Dependent Kinases; Disulfides; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; rho GTP-Binding Proteins; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53

2014

Diallyl disulfide inhibits N-acetyltransferase activity and gene expression in human esophagus epidermoid carcinoma CE 81T/VGH cells.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2005, Volume: 43, Issue:7

Topics: Acetylation; Acetyltransferases; Allyl Compounds; Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Disulfides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Esophageal Neoplasms; Female; Flow Cytometry; Humans; Mice; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm

2005